PT Itama Ranoraya Tbk (IRRA.JK)
IDR 400.0
(-1.48%)
IDR 400.0
(-1.48%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.37 IDR | -89.02% |
| 2022 | 30.68 IDR | -57.97% |
| 2021 | 73.00 IDR | 83.46% |
| 2020 | 39.79 IDR | 91.76% |
| 2019 | 20.75 IDR | 2.93% |
| 2018 | 20.16 IDR | 34.58% |
| 2017 | 14.98 IDR | 3304.55% |
| 2016 | 0.44 IDR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 7.45 IDR | 148.33% |
| 2024 Q1 | 2.86 IDR | 142.75% |
| 2024 Q2 | 3.00 IDR | 4.9% |
| 2023 Q2 | 3.93 IDR | -5.07% |
| 2023 FY | - IDR | -89.02% |
| 2023 Q3 | 1.71 IDR | -56.49% |
| 2023 Q4 | -6.69 IDR | -491.23% |
| 2023 Q1 | 4.14 IDR | -13.93% |
| 2022 FY | - IDR | -57.97% |
| 2022 Q4 | 4.81 IDR | 59.8% |
| 2022 Q3 | 3.01 IDR | -67.42% |
| 2022 Q2 | 9.24 IDR | -32.16% |
| 2022 Q1 | 13.62 IDR | -24.96% |
| 2021 Q1 | 14.00 IDR | -16.17% |
| 2021 FY | - IDR | 83.46% |
| 2021 Q4 | 18.15 IDR | -20.36% |
| 2021 Q3 | 22.79 IDR | 14.58% |
| 2021 Q2 | 19.89 IDR | 42.07% |
| 2020 Q2 | 4.73 IDR | 237.86% |
| 2020 Q1 | 1.40 IDR | -91.81% |
| 2020 FY | - IDR | 91.76% |
| 2020 Q4 | 16.70 IDR | -2.79% |
| 2020 Q3 | 17.18 IDR | 263.21% |
| 2019 Q2 | 1.57 IDR | 11.35% |
| 2019 FY | - IDR | 2.93% |
| 2019 Q1 | 1.41 IDR | 0.0% |
| 2019 Q3 | 0.89 IDR | -43.31% |
| 2019 Q4 | 17.10 IDR | 1821.35% |
| 2018 Q1 | 2.69 IDR | 0.0% |
| 2018 FY | - IDR | 34.58% |
| 2017 FY | - IDR | 3304.55% |
| 2016 FY | - IDR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 254.19 IDR | 98.674% |
| PT Kimia Farma (Persero) Tbk | -267.48 IDR | 101.26% |
| PT Millennium Pharmacon International Tbk | 25.97 IDR | 87.023% |
| PT Soho Global Health Tbk | 29.26 IDR | 88.483% |